These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17559599)

  • 1. Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care.
    Niaz OS; Haddad PM
    Acta Psychiatr Scand; 2007 Jul; 116(1):36-46. PubMed ID: 17559599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of risperidone long-acting injection in the treatment of schizophrenia and schizoaffective disorders in Hong Kong: an approach using generalised estimating equations.
    Wu DB; Lee EH; Chung WS; Chow DP; Lee VW; Wong MC; Lee KK
    Psychiatry Res; 2013 Dec; 210(3):745-50. PubMed ID: 24012164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Explicit review of risperidone long-acting injection prescribing practice.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: a one-year mirror-image study with national claim-based database in Taiwan.
    Chang HC; Tang CH; Huang ST; McCrone P; Su KP
    J Psychiatr Res; 2012 Jun; 46(6):751-6. PubMed ID: 22440883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries.
    Peuskens J; Olivares JM; Pecenak J; Tuma I; Bij de Weg H; Eriksson L; Resseler S; Akhras K; Jacobs A
    Curr Med Res Opin; 2010 Mar; 26(3):501-9. PubMed ID: 20014981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse and long-acting injectable risperidone: a 1-year mirror image study with a national claims database in Taiwan.
    Su KP; Chang HC; Tsai SJ; Yen FC; Tang CH
    Value Health; 2009; 12 Suppl 3():S118-21. PubMed ID: 20586973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.
    Taylor DM; Young CL; Mace S; Patel MX
    J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis.
    Carswell C; Wheeler A; Vanderpyl J; Robinson E
    Clin Drug Investig; 2010; 30(11):777-87. PubMed ID: 20712387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year treatment continuation in patients prescribed risperidone long-acting injection in New Zealand: a retrospective study.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):61-8. PubMed ID: 22776632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain - a cost-effectiveness comparison.
    Dilla T; Möller J; O'Donohoe P; Álvarez M; Sacristán JA; Happich M; Tockhorn A
    BMC Psychiatry; 2014 Dec; 14():298. PubMed ID: 25438678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M; Sapin C; Beillat M; Robinson P; Treur M
    J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.
    Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E
    Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens.
    Fu DJ; Bossie CA; Kern Sliwa J; Ma YW; Alphs L
    Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):101-9, 109A. PubMed ID: 23446197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of risperidone long acting injection on resource utilization in psychiatric secondary care.
    Taylor M; Currie A; Lloyd K; Price M; Peperell K
    J Psychopharmacol; 2008 Mar; 22(2):128-31. PubMed ID: 18308820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada.
    Lammers L; Zehm B; Williams R
    BMC Psychiatry; 2013 May; 13():155. PubMed ID: 23718192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of risperidone long-acting injection in the treatment of schizophrenia.
    Chue P; Chue J
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):259-69. PubMed ID: 22812548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study.
    Chan HW; Huang CY; Feng WJ; Yen YC
    Psychiatry Clin Neurosci; 2015 Aug; 69(8):497-503. PubMed ID: 25781185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database.
    Hsieh MH; Chuang PY; Wu CS; Chang CJ; Chung PF; Tang CH
    J Affect Disord; 2017 Aug; 218():327-334. PubMed ID: 28494390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use.
    Taylor D; Fischetti C; Sparshatt A; Thomas A; Bishara D; Cornelius V
    Acta Psychiatr Scand; 2009 Aug; 120(2):97-101. PubMed ID: 19207128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.